Targeting the epidermal growth factor receptor: a clinical reality.
Baselga
J
J
Vall d'Hebron University Hospital, Barcelona, Spain. baselga@hg.vhebron.es
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001667:Binding, Competitive; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology / Q000378:metabolism* / Q000502:physiology*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008024:Ligands; D009369:Neoplasms / Q000276:immunology / Q000503:physiopathology; D015398:Signal Transduction
D000911:Antibodies, Monoclonal; D008024:Ligands; D066246:ErbB Receptors